Terms: = Lung cancer AND AFF3, MLLT2-like, 3899, ENSG00000144218, LAF4, P51826
10 results:
1. The Underlying Mechanism Involved in Gefitinib Resistance and Corresponding Experiment Validation in lung cancer.
Song P; Zhou J; Wu K; Wang W; Gu S
Mediators Inflamm; 2023; 2023():9658912. PubMed ID: 37205010
[TBL] [Abstract] [Full Text] [Related]
2. Phenotype and Outcomes of Pulmonary Hypertension Associated with Neurofibromatosis Type 1.
Jutant EM; Jaïs X; Girerd B; Savale L; Ghigna MR; Perros F; Mignard X; Jevnikar M; Bourlier D; Prevot G; Tromeur C; Bauer F; Bergot E; Dauphin C; Favrolt N; Traclet J; Soumagne T; De Groote P; Chabanne C; Magro P; Bertoletti L; Gueffet JP; Chaouat A; Goupil F; Moceri P; Borie R; Fadel E; Wolkenstein P; Brillet PY; Simonneau G; Sitbon O; Humbert M; Montani D
Am J Respir Crit Care Med; 2020 Sep; 202(6):843-852. PubMed ID: 32437637
[No Abstract] [Full Text] [Related]
3. Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
Zhang DL; Qu LW; Ma L; Zhou YC; Wang GZ; Zhao XC; Zhang C; Zhang YF; Wang M; Zhang MY; Yu H; Sun BB; Gao SH; Cheng X; Guo MZ; Huang YC; Zhou GB
Cancer Lett; 2018 Oct; 434():132-143. PubMed ID: 30031117
[TBL] [Abstract] [Full Text] [Related]
4. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract] [Full Text] [Related]
5. High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA).
Baty F; Klingbiel D; Zappa F; Brutsche M
J Biomed Inform; 2015 Dec; 58():175-185. PubMed ID: 26483173
[TBL] [Abstract] [Full Text] [Related]
6. Joint effects of environmental exposures and familial susceptibility to lung cancer in Chinese never smoking men and women.
Tse LA; Yu IT; Rothman N; Ji BT; Qiu H; Wang XR; Hu W; Au JS; Lan Q
J Thorac Oncol; 2014 Aug; 9(8):1066-72. PubMed ID: 24852518
[TBL] [Abstract] [Full Text] [Related]
7. The role of ThinPrep cytology in the investigation of lung tumors.
Konofaos P; Tomos P; Malagari K; Karakatsani A; Pavlopoulos D; Lachanas E; Flessas M; Kostakis A; Karakitsos P
Surg Oncol; 2006 Nov; 15(3):173-8. PubMed ID: 17275290
[TBL] [Abstract] [Full Text] [Related]
8. Metastatic pattern in non-resectable non-small cell lung cancer.
Stenbygaard LE; Sørensen JB; Larsen H; Dombernowsky P
Acta Oncol; 1999; 38(8):993-8. PubMed ID: 10665751
[TBL] [Abstract] [Full Text] [Related]
9. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators.
Gecz J; Bielby S; Sutherland GR; Mulley JC
Genomics; 1997 Sep; 44(2):201-13. PubMed ID: 9299237
[TBL] [Abstract] [Full Text] [Related]
10. LAF-4 encodes a lymphoid nuclear protein with transactivation potential that is homologous to AF-4, the gene fused to MLL in t(4;11) leukemias.
Ma C; Staudt LM
Blood; 1996 Jan; 87(2):734-45. PubMed ID: 8555498
[TBL] [Abstract] [Full Text] [Related]
